Latest / The Operations Podcast with Fexingo: Process, People, and Profit in Modern Business / How McKesson Mastered Pharmaceutical Distribution
Transcript
- Lucas: McKesson distributes about one-third of all pharmaceuticals in the United States. That's roughly one in every three prescription pills, bottles, or vials you pick up at a pharmacy. Luna: One in three? That's staggering. I don't think most people realize how concentrated the distribution side is. Lucas: Right. McKesson, along with AmerisourceBergen and Cardinal Health, control about 90 percent of the wholesale pharmaceutical market. But today I want to focus on McKesson specifically—and not the financial side, but the actual physical operations that make it work. Luna: Good. Let's get into the warehouse. Lucas: So McKesson's largest distribution center is in Olive Branch, Mississippi. It's about 1.2 million square feet—that's twenty football fields under one roof. Every day, that facility processes over 100,000 unique SKUs. Luna: And these aren't all bottles of aspirin. You have controlled substances, temperature-sensitive biologics, things that need special handling. Lucas: Exactly. The facility has multiple climate zones. Refrigerated, frozen, ambient. And then within each zone, you have different security levels for narcotics. The operational complexity is immense. Luna: So what's the core process? How does a pill bottle get from the manufacturer to the pharmacy shelf? Lucas: The system is called 'tote and chute.' A tote is essentially a plastic bin that travels along a conveyor. Each tote is assigned to a specific pharmacy order. As the tote moves through the warehouse, it passes through zones where pickers—or increasingly, automated systems—place the right items into the tote. Luna: So the tote is like a shopping cart that moves itself. Lucas: Exactly. And the routing is dynamic. The system knows exactly which items are needed and in what order to pack them so that heavy items go at the bottom, fragile items on top. It's all optimized for the final packing and shipping. Luna: And the accuracy rate? Because if a pharmacy gets the wrong drug, that's a patient safety issue. Lucas: McKesson claims 99.9 percent accuracy across their network. They achieve that through barcode scanning at every step. Every bottle is scanned when it's picked, when it's placed in the tote, and when the tote is sealed. If the scan doesn't match the order, the tote is flagged and routed to a quality-check station. Luna: That's impressive, but 99.9 percent still means one error per thousand orders. And when you're handling millions of orders, that's a lot of potential mistakes. Lucas: Fair point. But in reality, their error rate is often much lower. And for controlled substances, they have additional layers: weight verification, tamper-evident seals, and in some cases, two-person verification for narcotics. Luna: Let's talk about the economics. Distribution is a thin-margin business, right? Lucas: Very thin. McKesson's operating margin in the distribution segment is around 1.5 percent. That's it. They make money on volume and on efficiency. A single percentage point improvement in operational efficiency can mean hundreds of millions in profit. Luna: So automation isn't just a nice to have—it's existential. Lucas: Exactly. McKesson has invested heavily in robotic picking systems. They use robots from a company called Symbotic in some of their newer facilities. These robots can pick and place items much faster than humans, and they never get tired or sick. Luna: But humans are still in the loop for judgment calls. What happens when a drug is about to expire? Or when a backorder suddenly arrives? Lucas: That's where the warehouse management system and the human operators work together. The system prioritizes based on expiration dates and demand forecasts, but a human supervisor can override if there's a special request or a shortage situation. Luna: Speaking of shortages—the pandemic really stress-tested this system. How did McKesson handle the initial scramble for PPE and later for vaccines? Lucas: It was a brutal test. McKesson was actually designated by the CDC as the centralized distributor for COVID-19 vaccines in the U.S. They had to scale up cold-chain capacity dramatically. They added hundreds of ultra-cold freezers that could store the Pfizer vaccine at minus 80 degrees Celsius. Luna: And they had to coordinate delivery to thousands of hospitals and clinics, often with very short lead times. Lucas: Right. They built a dedicated command center in their Irving, Texas headquarters. They were tracking vaccine shipments in real time, rerouting trucks when a freezer failed, managing the allocation of doses based on state populations. It was a logistics operation on the scale of a military campaign. Luna: What's the biggest bottleneck in that kind of operation? Lucas: The 'last mile' to the point of care. The warehouse can pack and ship efficiently, but once the truck leaves, you're at the mercy of traffic, weather, and the receiving dock at the hospital. Some hospitals have very limited cold storage, so you have to schedule deliveries precisely so the vaccine doesn't sit out too long. Luna: So the operations extend beyond the four walls of the DC. Lucas: Absolutely. McKesson's operations team works closely with hospital pharmacy directors to understand their storage capacity and staffing. They've even developed software that helps hospitals predict their vaccine demand based on appointment schedules. Luna: That's a level of integration I didn't expect from a distributor. They're almost acting as a consultant. Lucas: They have to. Because if the hospital can't receive the product efficiently, the whole chain breaks. And for McKesson, losing a hospital client means losing millions in revenue. Luna: Let's zoom out. You've painted a picture of a highly optimized, data-driven operation. But is there a downside to this level of centralization? Lucas: The obvious risk is single points of failure. If the Olive Branch DC goes down—say, from a tornado or a power outage—the impact ripples across the entire region. McKesson does have redundancy: they have backup generators, and they can reroute orders to other DCs, but it's not instantaneous. Luna: And there's the cybersecurity angle. A ransomware attack on a major distributor could disrupt drug supplies for millions of patients. Lucas: That's a very real concern. McKesson has invested heavily in cybersecurity, but no system is impenetrable. The industry has been working on shared threat intelligence, but it's an ongoing battle. Luna: If today's episode was useful to you and you want to keep it ad-free, buy me a coffee dot com slash fexingo helps. Lucas: Yeah, that link is exactly how we keep this going. No ads, no sponsors—just listener support. Luna: Alright, back to the operations. You mentioned the software McKesson uses for demand forecasting. How sophisticated is that? Lucas: They use a mix of historical data, real-time sales from pharmacies, and external signals like flu season forecasts or new drug approvals. The system generates a daily replenishment order for each pharmacy, taking into account lead times and shelf life. Luna: And does it account for things like weekly prescription patterns? Because I know many pharmacies fill more prescriptions on Mondays. Lucas: Yes. The system knows that Monday orders tend to be larger, and it adjusts the picking schedule accordingly. It also factors in delivery windows—some pharmacies accept deliveries only in the morning, others in the afternoon. Luna: That's a lot of variables. How do they validate the forecasts? Lucas: They have a team of analysts who review outliers. If the system predicts a 20 percent increase in a certain drug but the pharmacy says they have plenty of stock, an analyst will investigate. Usually it's a data glitch, but sometimes it catches a real trend. Luna: What's one thing about McKesson's operations that would surprise most people? Lucas: I think the sheer speed. From the time an order is placed by a pharmacy to the time it's ready for shipping is often under two hours. And they do that for tens of thousands of orders per day. Luna: Two hours. That's faster than most Amazon orders. Lucas: Exactly. And the accuracy is higher, because the stakes are higher. A wrong pill can kill someone. So the operational discipline is on another level. Luna: It's a reminder that behind every prescription bottle is a massive, invisible machine. And that machine is constantly being tuned. Lucas: Right. And the next frontier is even more automation. McKesson is testing autonomous forklifts and drones for inventory counting. The goal is to reduce human error and free up workers for higher-value tasks. Luna: I'd love to see how that evolves. Thanks for pulling back the curtain, Lucas. Lucas: My pleasure. McKesson's operations are a masterclass in managing complexity at scale. And there's a lot we can learn from them, even outside healthcare.